• Anti-cd20 agents for multiple sclerosis: Spotlight on ocrelizumab and ofatumumab 

      Florou D., Katsara M., Feehan J., Dardiotis E., Apostolopoulos V. (2020)
      Until recently, in the pathogenesis of Multiple Sclerosis (MS), the contribution of B cells has been largely underestimated, and the disease was considered a T-cell-mediated disorder. However, newer evidence shows that B ...
    • Intestinal microbiota and colorectal cancer: A new aspect of research 

      Koliarakis I., Psaroulaki A., Nikolouzakis T.K., Kokkinakis M., Sgantzos M.N., Goulielmos G., Androutsopoulos V.P., Tsatsakis A., Tsiaoussis J. (2018)
      Colon holds a complex microbial community, which is crucial for maintaining homeostasis and regulating metabolic functions, supporting the intestinal barrier and controlling immune responses. Previous studies have supported ...
    • Systemic sclerosis: New evidence re-enforces the role of B cells 

      Sakkas L.I., Bogdanos D.P. (2016)
      Systemic sclerosis (SSc) is characterized by widespread fibrosis, microangiopathy (vasospasms and stenosis), and formation of autoantibodies. T cell activation has been shown to contribute to fibrosis and microvasculopathy ...